Advanced search    

Search: authors:"Eva Szabo"

7 papers found.
Use AND, OR, NOT, +word, -word, "long phrase", (parentheses) to fine-tune your search.

Impact of mesenteric defect closure technique on complications after gastric bypass

technique may be safely performed. Authors’ contributions Study conception and design—Erik Stenberg Acquisition of data—Erik Stenberg, Ingmar Näslund, Eva Szabo, Johan Ottosson Analysis and interpretation ... of data—Erik Stenberg, Ingmar Näslund, Eva Szabo, Johan Ottosson Drafting of manuscript—Erik Stenberg Critical revision of manuscript—Ingmar Näslund, Eva Szabo, Johan Ottosson Funding This work was

Risk Prediction Model for Severe Postoperative Complication in Bariatric Surgery

Background Factors associated with risk for adverse outcome are important considerations in the preoperative assessment of patients for bariatric surgery. As yet, prediction models based on preoperative risk factors have not been able to predict adverse outcome sufficiently. Objective This study aimed to identify preoperative risk factors and to construct a risk prediction model...

Health-Related Quality-of-Life after Laparoscopic Gastric Bypass Surgery with or Without Closure of the Mesenteric Defects: a Post-hoc Analysis of Data from a Randomized Clinical Trial

Standards Conflict of Interest Ingmar Näslund has received consultant fees from Baricol Bariatrics AB, Sweden. Erik Stenberg, Eva Szabo, Johan Ottosson, and Anders Thorell declare that they have no conflict

Alterations of bone mineral density, bone microarchitecture and strength in patients with ankylosing spondylitis: a cross-sectional study using high-resolution peripheral quantitative computerized tomography and finite element analysis

Introduction Ankylosing spondylitis (AS) is an inflammatory disease associated with new bone formation and an increased risk of osteoporosis and fractures. The negative effects of AS on bone microarchitecture and strength are unclear. Thus, we conducted an observational study to analyze the effect of AS on bone microarchitecture and strength. Methods Patients with AS (n = 53) and...

Lung Cancer and Chronic Obstructive Pulmonary Disease: Needs and Opportunities for Integrated Research

; Gail Weinmann, MD, Division of Lung Diseases. National Cancer Institute staff: Eva Szabo, MD, Division of Cancer Prevention. Manuscript received October 6, 2008; revised January 2, 2009; accepted

Prevention of mouse lung tumors by budesonide and its modulation of biomarkers

Chemopreventive drugs have the potential to decrease the morbidity and mortality of lung cancer. The development of these drugs could be expedited by the application of surrogate end-point biomarkers that demonstrate chemopreventive efficacy. In this study, the ability of budesonide to prevent lung tumors in mice was characterized further and its effects on biomarkers were...